Detalhe da pesquisa
1.
Molecular specific and cell selective cytotoxicity induced by a novel synthetic HLA-DR antibody mimic for lymphoma and leukemia.
Int J Oncol
; 34(2): 511-6, 2009 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-19148487
2.
NanoFerrite particle based radioimmunonanoparticles: binding affinity and in vivo pharmacokinetics.
Bioconjug Chem
; 19(6): 1211-8, 2008 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-18517234
3.
A new era for radiolabeled antibodies in cancer?
Curr Opin Immunol
; 11(5): 563-9, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10508716
4.
Stable bifunctional chelates of metals used in radiotherapy.
Cancer Res
; 50(3 Suppl): 789s-793s, 1990 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2297725
5.
Radioimmunotherapy for breast cancer using escalating fractionated doses of 131I-labeled chimeric L6 antibody with peripheral blood progenitor cell transfusions.
Cancer Res
; 55(23 Suppl): 5916s-5920s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493370
6.
Effect of the extent of chelate substitution on the immunoreactivity and biodistribution of 2IT-BAT-Lym-1 immunoconjugates.
Cancer Res
; 55(4): 878-84, 1995 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-7850803
7.
Effect of mass of 111In-benzyl-EDTA monoclonal antibody on hepatic uptake and processing in mice.
Cancer Res
; 49(7): 1707-11, 1989 Apr 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2493983
8.
Fractionated radioimmunotherapy of B-cell malignancies with 131I-Lym-1.
Cancer Res
; 50(3 Suppl): 1014s-1016s, 1990 Feb 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-2297713
9.
Prelabeling of chimeric monoclonal antibody L6 with 90yttrium- and 111indium-1,4,7,10-tetraazacyclododecane-N,N',N",N"'-tetraacetic acid (DOTA) chelates for radioimmunodiagnosis and therapy.
Cancer Res
; 55(23 Suppl): 5726s-5728s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493335
10.
Prognostic factors for radioimmunotherapy in patients with B-lymphocytic malignancies.
Cancer Res
; 55(23 Suppl): 5893s-5898s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493366
11.
Yttrium-90 chimeric L6 therapy of human breast cancer in nude mice and apoptosis-related messenger RNA expression.
Cancer Res
; 55(23 Suppl): 5837s-5841s, 1995 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-7493356
12.
Radioimmunotherapy: recent results and future directions.
J Clin Oncol
; 14(4): 1383-400, 1996 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-8648397
13.
Maximum-tolerated dose, toxicity, and efficacy of (131)I-Lym-1 antibody for fractionated radioimmunotherapy of non-Hodgkin's lymphoma.
J Clin Oncol
; 16(10): 3246-56, 1998 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-9779698
14.
Accuracy of Doppler catheter measurements: effect of inhomogeneous beam power distribution on mean and peak velocity.
J Am Coll Cardiol
; 29(2): 283-92, 1997 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-9014979
15.
Development of a hyperimmune anti-MUC-1 single chain antibody fragments phage display library for targeting breast cancer.
Clin Cancer Res
; 5(10 Suppl): 3088s-3094s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541348
16.
Efficacy and toxicity of 67Cu-2IT-BAT-Lym-1 radioimmunoconjugate in mice implanted with human Burkitt's lymphoma (Raji).
Clin Cancer Res
; 3(1): 71-9, 1997 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-9815540
17.
Treatment-related parameters predicting efficacy of Lym-1 radioimmunotherapy in patients with B-lymphocytic malignancies.
Clin Cancer Res
; 3(8): 1253-60, 1997 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-9815807
18.
67Cu-versus 131I-labeled Lym-1 antibody: comparative pharmacokinetics and dosimetry in patients with non-Hodgkin's lymphoma.
Clin Cancer Res
; 5(3): 533-41, 1999 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-10100704
19.
Effect of 67Cu-2IT-BAT-Lym-1 therapy on BCL-2 gene and protein expression in a lymphoma mouse model.
Clin Cancer Res
; 5(10 Suppl): 3010s-3014s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541336
20.
Antibody phage libraries for the next generation of tumor targeting radioimmunotherapeutics.
Clin Cancer Res
; 5(10 Suppl): 3213s-3218s, 1999 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-10541366